These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 7936100)
21. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo. Zetterström T; Sharp T; Ungerstedt U Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964 [TBL] [Abstract][Full Text] [Related]
22. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Borowsky B; Kuhn CM Neuropharmacology; 1992 Jul; 31(7):671-8. PubMed ID: 1328919 [TBL] [Abstract][Full Text] [Related]
23. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors. Zackheim JA; Abercrombie ED Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986 [TBL] [Abstract][Full Text] [Related]
24. Selective inactivation of dopamine D1 and D2 receptors in 6-hydroxydopamine-lesioned rats: evidence that the effect of D1 and D2 agonists can be expressed in the absence of the heterologous DA receptor. Arnt J; Hyttel J Pharmacol Toxicol; 1989 Jan; 64(1):116-9. PubMed ID: 2526946 [TBL] [Abstract][Full Text] [Related]
25. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors. Meller E; Hizami R; Kreuter L Pharmacol Biochem Behav; 1989 Jan; 32(1):141-5. PubMed ID: 2567521 [TBL] [Abstract][Full Text] [Related]
26. Effects of selective dopamine receptor compounds on single, spontaneously-active neostriatal neurons. Nantwi KD; Schoener EP Gen Pharmacol; 1994 Nov; 25(7):1439-43. PubMed ID: 7896058 [TBL] [Abstract][Full Text] [Related]
27. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
28. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG; Walters JR Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219 [TBL] [Abstract][Full Text] [Related]
29. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate. Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140 [TBL] [Abstract][Full Text] [Related]
30. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630 [TBL] [Abstract][Full Text] [Related]
31. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine. Acquas E; Di Chiara G Eur J Pharmacol; 1999 Oct; 383(2):121-7. PubMed ID: 10585525 [TBL] [Abstract][Full Text] [Related]
32. D-cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain. Gandolfi O; Rimondini R; Dall'Olio R Pharmacol Biochem Behav; 1994 Jun; 48(2):351-6. PubMed ID: 7916464 [TBL] [Abstract][Full Text] [Related]
33. Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements. Rosengarten H; Schweitzer JW; Egawa M; Friedhoff AJ Adv Exp Med Biol; 1988; 235():159-67. PubMed ID: 2976249 [TBL] [Abstract][Full Text] [Related]
34. Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra. Hemsley KM; Crocker AD Neuropsychopharmacology; 2001 Oct; 25(4):514-26. PubMed ID: 11557165 [TBL] [Abstract][Full Text] [Related]
35. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies. Abarca J; Gysling K; Roth RH; Bustos G Neurochem Res; 1995 Feb; 20(2):159-69. PubMed ID: 7783840 [TBL] [Abstract][Full Text] [Related]
36. Behavioral effects of dopamine receptor inactivation in the caudate-putamen of preweanling rats: role of the D2 receptor. Der-Ghazarian T; Widarma CB; Gutierrez A; Amodeo LR; Valentine JM; Humphrey DE; Gonzalez AE; Crawford CA; McDougall SA Psychopharmacology (Berl); 2014 Feb; 231(4):651-62. PubMed ID: 24057816 [TBL] [Abstract][Full Text] [Related]
37. Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation. Dewar KM; Paquet M; Reader TA Neurochem Int; 1997 Jun; 30(6):613-21. PubMed ID: 9153003 [TBL] [Abstract][Full Text] [Related]
39. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. Ikemoto S; Glazier BS; Murphy JM; McBride WJ J Neurosci; 1997 Nov; 17(21):8580-7. PubMed ID: 9334429 [TBL] [Abstract][Full Text] [Related]
40. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study. Hu XT; Wang RY J Neurosci; 1988 Nov; 8(11):4340-8. PubMed ID: 2972814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]